New Age Alpha Advisors LLC Makes New $1.41 Million Investment in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

New Age Alpha Advisors LLC bought a new stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 21,922 shares of the company’s stock, valued at approximately $1,407,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Rakuten Securities Inc. acquired a new stake in Ryan Specialty in the fourth quarter valued at about $27,000. Principal Securities Inc. boosted its stake in shares of Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after purchasing an additional 415 shares in the last quarter. Quarry LP grew its holdings in shares of Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after purchasing an additional 422 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new position in Ryan Specialty during the 4th quarter worth approximately $54,000. Finally, R Squared Ltd bought a new position in Ryan Specialty in the 4th quarter valued at approximately $92,000. Institutional investors own 84.82% of the company’s stock.

Insider Transactions at Ryan Specialty

In other news, Director Nicholas Dominic Cortezi sold 10,485 shares of the firm’s stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $65.12, for a total value of $682,783.20. Following the completion of the sale, the director now directly owns 11,109 shares in the company, valued at $723,418.08. This trade represents a 48.56 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the business’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. Insiders sold a total of 241,360 shares of company stock valued at $16,006,428 in the last quarter. 11.10% of the stock is currently owned by company insiders.

Ryan Specialty Price Performance

Shares of NYSE RYAN opened at $72.98 on Monday. The company has a market capitalization of $19.11 billion, a PE ratio of 105.77, a P/E/G ratio of 1.19 and a beta of 0.71. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $75.97. The firm has a fifty day simple moving average of $68.74 and a 200 day simple moving average of $68.32.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business had revenue of $663.53 million during the quarter, compared to the consensus estimate of $658.80 million. On average, sell-side analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.66%. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Tuesday, March 4th. Ryan Specialty’s dividend payout ratio is presently 69.57%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Royal Bank of Canada decreased their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a research note on Friday, February 21st. Morgan Stanley started coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price for the company. Keefe, Bruyette & Woods cut their price target on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a research note on Friday, February 21st. Wells Fargo & Company upped their price objective on Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research note on Friday, February 21st. Finally, UBS Group raised their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $75.27.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.